Smokeless Tobacco and Some Tobacco-specific N-nitrosamines


Book Description

This eighty-ninth volume of the IARC Monographs is the third and last of a series on tobacco-related agents. Volume 83 reported on the carcinogenicity of tobacco smoke and involuntary smoking (second-hand smoke or environmental tobacco smoke) (IARC 2004a). Volume 85 summarized the evidence on the carcinogenic risk of chewing betel quid with and without tobacco (IARC 2004b). That volume explored the variety of products chewed in South Asia and other parts of the word that contain areca nut in combination with other ingredients, often including tobacco. In this eighty-ninth volume, the carcinogenic risks associated with the use of smokeless tobacco, including chewing tobacco and snuff, are considered in a first monograph. The second monograph reviews some tobacco-specific nitrosamines. These agents were evaluated earlier in Volume 37 of the Monographs (IARC 1985) and information gathered since that time has been summarized and evaluated.




For Smokers Only


Book Description

If you smoke and are unable or unwilling to quit, this approach can save your life. The book, For Smokers Only: How Smokeless Tobacco Can Save Your Life, provides concrete facts and valuable advice on a revolutionary quit-smoking strategy that is based on scientific research and common sense. Itis written by Dr. Brad Rodu, a leading authority on tobacco harm reduction, and a professor and senior scientist at the University of Alabama/Birmingham Comprehensive Cancer Center. Dr. Roduis stop-smoking strategy is based on three simple facts: 1. Smokers are addicted to nicotine, but nicotine does not cause cancer, heart attacks or emphysema. Those illnesses are caused by the other 3000 products of tobacco combustion. 2. Smokeless tobacco satisfies nicotine craving, but smokeless is 98% safer than smoking. 3. Todayis smokeless, spitless tobacco products can be used invisibly anytime, anywhere, much like a breath mint. "Please surf this site for lots of useful, factual information that can save your life, and the lives of your friends and loved ones." -- Dr. Brad Rodu"




Smokeless Tobacco Products


Book Description

Smokeless Tobacco Products: Characteristics, Usage, Health Effects, and Regulatory Implications, a title in the Emerging Issues in Analytical Chemistry series, presents an overview of research on the second most dangerous tobacco product. This book presents findings on public health risks emanating from the complex interaction between smokeless tobacco products and their users. It covers the key components of assessment and provides insight into scientific and public health considerations. The book does not take a simplistic condemnatory position, but rather conceptualizes tobacco use in terms of graduated public health danger and harm reduction. The book begins by introducing smokeless tobacco, its history of use, marketing, and implications for public health. It then continues with coverage of epidemiology, pathology and clinical implications, addiction, and treatment, and includes laboratory studies of human use. The following section explains the chemistry, biochemical mechanisms of carcinogenesis, and role of plant cultivation and manufacturing in toxicity. Finally, the book concludes by addressing regulatory considerations, the scientific basis of regulations, and the role of these products in harm reduction for smokers. This is the first resource of its kind to cover these topics together and in language appropriate to both specialists in the research community and informed persons responsible for legislative, funding, and public health matters in the community at large. - Brings attention to smokeless tobacco product use and its association with addiction and disease - Considers smokeless tobacco use historically and currently, as well as its place in a future harm-reduction conceptualization of tobacco - Written by a distinguished, internationally recognized group of tobacco researchers from academia, independent research organizations, and the federal government with expertise in the many and various disciplines covered




Snus!


Book Description

The very first tell-all snus encyclopedia of its kind! You don't have to light up to enjoy tobacco! Swedish snus has a unique position in the world and is continually being developed through a thorough choice of tobacco, well­-tested flavorings, and high quality production methods. Both large and small producers employ master blenders in order to create new and exciting snus products—all based on over 200 years of global expertise. A unique snus culture is developing and it’s one that has an exciting future ahead of it. More and more snus users are finding their way around the rich and varied range of products available and are starting to discover the rewards of choosing different snus varieties for different occasions. Today’s users take knowledge seriously, and just as we do with drinks, for example, we match our snus to different occasions. Snus is well on its way to becoming an integral component of the gastronomical experience. This volume on snus is the first of its kind. It covers today's modern snus, how it’s manufactured and who makes it, as well as which factors influence the end-result. It also goes over the history of snus, the myths that surround it, its failures, and its successes. The book also tells you how to taste-test and rate snus—and the art of enjoying it. It offers advice on how to buy and store it, and guides you through more than 200 tested and ranked varieties of snus.




Smokeless Tobacco: Not a Safe Alternative


Book Description

For years now we've all heard the dangers of smoking cigarettes. To avoid those health risks, many people have turned to "chew," "plug," "chaw"-smokeless tobacco. No smoke, no danger. Right?




A Review of Human Carcinogens


Book Description




Tobacco and Health


Book Description

Over 1,100 delegates from a hundred countries attended the 9th World Conference onTobaccoandHealth. Afterfivedaysofdebate, severalimportantresolutionswereadopted unanimously and will be landmarks in the fight against tobacco. This great success is due to three facts which emerged from the discussions: 1. Itappears clearlynowthattherisksassociated withtobaccoaremuchgreaterthan previously assumed. Out of two regular smokers, one will die from a tobacco­ related disease. 2. Reducing tobacco consumption can be achieved but the data collected in several countriesshowthatitrequiresaglobalstrategy.Thisstrategywasmuchdebatedduring theconference. Theresolutionsadoptedemphasizetheagreementofthedelegateson themainpoints. Actionto fight thegrowingepidemicoftobacco-attributabledisease and death involves convincing the general public, the medical community and decision-makers ofthe need to act for tobacco control. The most efficient tools for helping individuals never to start or successfully to stop using tobacco should be developed; effective tobacco control endeavors are required to counteractthe actions ofthe powerful and influential tobacco manufacturers. With the help and under the aegis ofWHO, DICC, IUATLD, ISFC, IOCD, and IUHPE, an international alliance for health and against tobacco shouldunite all those who are engaged in this fight.




Nicotine Psychopharmacology


Book Description

The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: “The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . ”(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some “- ceptive substance” to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).




Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products


Book Description

Tobacco use by adolescents and young adults poses serious concerns. Nearly all adults who have ever smoked daily first tried a cigarette before 26 years of age. Current cigarette use among adults is highest among persons aged 21 to 25 years. The parts of the brain most responsible for cognitive and psychosocial maturity continue to develop and change through young adulthood, and adolescent brains are uniquely vulnerable to the effects of nicotine. At the request of the U.S. Food and Drug Administration, Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products considers the likely public health impact of raising the minimum age for purchasing tobacco products. The report reviews the existing literature on tobacco use patterns, developmental biology and psychology, health effects of tobacco use, and the current landscape regarding youth access laws, including minimum age laws and their enforcement. Based on this literature, the report makes conclusions about the likely effect of raising the minimum age to 19, 21, and 25 years on tobacco use initiation. The report also quantifies the accompanying public health outcomes based on findings from two tobacco use simulation models. According to the report, raising the minimum age of legal access to tobacco products, particularly to ages 21 and 25, will lead to substantial reductions in tobacco use, improve the health of Americans across the lifespan, and save lives. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products will be a valuable reference for federal policy makers and state and local health departments and legislators.